Detalhe da pesquisa
1.
Tominersen in Adults with Manifest Huntington's Disease.
N Engl J Med
; 389(23): 2203-2205, 2023 Dec 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38055260
2.
Mathematical Disease Progression Modeling in Type 2/3 Spinal Muscular Atrophy.
Muscle Nerve
; 58(4): 528-535, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29938801
3.
The effect of aleglitazar on the pharmacokinetics and pharmacodynamics of S- and R-warfarin in healthy male subjects.
J Cardiovasc Pharmacol
; 63(2): 152-7, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24157957
4.
Development of a population pharmacokinetic model to characterize the pharmacokinetics of intrathecally administered tominersen in cerebrospinal fluid and plasma.
CPT Pharmacometrics Syst Pharmacol
; 12(9): 1213-1226, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37221972
5.
Randomized, Double-Blind, Placebo-Controlled Trial of the mGlu2/3 Negative Allosteric Modulator Decoglurant in Partially Refractory Major Depressive Disorder.
J Clin Psychiatry
; 81(4)2020 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32663909
6.
Subcutaneous Bioavailability of Taspoglutide at 3 Different Injection Sites in Healthy Overweight/Obese Subjects.
Clin Ther
; 37(11): 2439-48, 2015 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26412802